SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?
作者信息
Patoulias Dimitrios, Michailidis Theodoros
机构信息
Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration," Thessaloniki, Greece.
Second Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration," Thessaloniki, Greece.
出版信息
J Clin Transl Hepatol. 2022 Aug 28;10(4):574-576. doi: 10.14218/JCTH.2022.00278. Epub 2022 Jul 13.
Abstract
摘要
Zotero 插件